Forbes contributors publish independent expert analyses and insights. John Sviokla covers GenAI/AI's impact on commerce and society. This voice experience is generated by AI. Learn more. This voice ...

On Tuesday, OpenAI introduced dynamic visual explanations, a new ChatGPT feature that allows users to see how formulas, variables, and mathematical relationships change in real time. Instead of just ...

Whether they want to admit it or not, Amazon, Walmart, Kroger and other grocers engage in dynamic pricing, according to data access and proxy service provider Decodo. Decodo released a list Monday of ...

Macworld reports that Apple’s iPhone 18 Pro may feature the first-ever redesign of the Dynamic Island, making it significantly smaller than current models. The redesign could utilize micro-transparent ...

Salt Lake City, UT, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today it will provide ...

Programming is the backbone of modern technology, and understanding a programming languages list is essential for developers, students, and tech enthusiasts. In 2026, Python leads AI and data science ...

Ricursive Intelligence, founded by two former Google researchers and valued at $4 billion, is among several efforts to automate the creation of artificial intelligence. Anna Goldie and Azalia ...

Across industries, pricing strategies are quietly shifting. What was once a predictable rhythm of annual increases is now giving way to continuous, incremental adjustments—and, in some cases, fully ...

One analyst tracking the biotech upgraded her recommendation on its shares. She now believes that they rate a buy, rather than a hold. 10 stocks we like better than Recursion Pharmaceuticals › An ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

Management reaffirmed guidance for 2025 on an expense base of less than $450 million, "excluding all of the partnership inflows." For 2026, guidance was also reaffirmed at less than $390 million.

Salt Lake City, UT, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today it will provide ...